News Articles Tagged: Oral Diabetes Medication

Orforglipron: A Game-Changer for Type 2 Diabetes Management

Explore Orforglipron (CAS 2212020-52-3), an oral GLP-1 receptor agonist for type 2 diabetes. Learn how its mechanism improves glycemic control and why it's a key pharmaceutical intermediate for suppliers.

Chlorpropamide API: The Foundation for Effective Diabetes Oral Medications

NINGBO INNO PHARMCHEM CO.,LTD. highlights Chlorpropamide API as a foundational element for manufacturing effective oral medications to treat type 2 diabetes.